Predicting Human Disease Risk from Animal-borne Pathogens Webinar

Predicting Human Disease Risk from Animal-borne Pathogens Webinar

Category : News/Events

Overview: 

This is a live webinar scheduled for July 28, 2022 at 12pm EST. You can find more information here. Please register for the event here.

Dr. Barbara Han, a disease ecologist at the Cary Institute of Ecosystem Studies, will explore recent approaches that combine knowledge about animal ecology with machine learning and artificial intelligence tools to make predictions about where and from which species the risks of zoonotic outbreaks are greatest. Examples will emphasize the ongoing spillback transmission of SARS-CoV-2 from humans to animals, the risk of establishing new viral reservoirs of COVID-19, and predicting wild reservoirs of bat-borne filoviruses (Ebola, Marburg) and rodent-borne pathogens such as monkeypox.

Dr. Han is a disease ecologist at the Cary Institute of Ecosystem Studies in New York. She completed her PhD at Oregon State University during which time she also completed a Fulbright Fellowship in Venezuela. Dr. Han went on to complete consecutive postdoctoral fellowships in biological informatics (NSF) and machine learning (NIH) at the University of Georgia. Her research program at the Cary Institute develops predictive analytics of zoonotic diseases and is supported by grants from the NIH, NSF, and DARPA.


Log out of this account

Leave a Reply

Upcoming Events

  • Charles R. Hatcher, Jr., MD. Award for Excellence in Public Health September 8, 2022 at 3:00 pm – 5:00 pm Lawrence P & Ann Estes Klamon Room Event Type: Guest LecturePresentation of award to Dr. James W. Curran, MD, MPH - Emeritus Dean, Rollins School of Public HealthFollowed by Reception
  • Striving to End Liver Cancer Symposium September 29, 2022 Chapel Hill, NC Event Type: Conference / SymposiumSeries: NoSpeaker: MultipleContact Name: Joellen SchildkrautContact Email: jmschil@emory.eduLink: https://unc.az1.qualtrics.com/jfe/form/SV_aVF8mu7OTr1QTLoThe Workshop goals are to introduce a new liver study, STRIVE. We also seek to guide research directions into liver cancer risk and progression.

Follow Us on Social Media: